2 hammered ASX shares to buy before they rise again: Celeste

If you're purchasing a house you'd want it for the lowest price. So why is it any different for stocks?

| More on:
A older man and younger man rest, exhausted but happy after a good boxing session.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you want to buy a car, you try to look for the best price. 

Who in their right mind would want to pay $50,000 if they can purchase the same vehicle for $40,000?

So it's irrational when investors are put off by ASX shares that have recently plunged in price.

If the business behind it is sound and has an exciting future, short-term discounting in the stock price should present a golden buying opportunity.

With this in mind, the analysts at Celeste Funds Management recently named two stocks in its portfolio that had a pretty ordinary December:

Still a quality company 

Shares for cooling systems provider PWR Holdings Ltd (ASX: PWH) have done outstandingly in the past year while most other stocks have struggled.

The stock price has rocketed more than 38% upwards over the last 12 months.

However, it detracted from the Celeste portfolio as 2022 ended, dipping a painful 8% in December.

Created with Highcharts 11.4.3PWR Holdings PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.com.au

In a memo to clients, the Celeste team noted that the Christmas fall came after a strong November rally on the back of its yearly financial results.

"While there were no new trading updates over the period, the stock was supported by a strong FY22 result that saw NPAT of $20.8 million (+23.9% vs pcp), 6.5% ahead of consensus expectations."

The analysts are "mindful" of how the share price has risen in recent times, but reckon more good times are ahead.

"We believe the committed order book, a strong balance sheet and the growth optionality in emerging technologies will underwrite earnings momentum over the near term."

Post-COVID recovery expected

Pathology services provider Australian Clinical Labs Ltd (ASX: ACL) watched in horror as its shares crashed 12.1% in December.

A longer timeframe doesn't do it any favours either, with the stock halving in value over the past 12 months.

The Celeste team attributed the disastrous showing to two factors.

"The first is revenue generated from COVID testing. With Australia well into the endemic phase of COVID-19, the number of COVID tests and government funding for those tests has declined precipitously," the memo read.

"This should not have come as a surprise, but consensus estimates have been slow to come down."

Created with Highcharts 11.4.3PWR Holdings PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.com.au

The second issue is the recovery in "business-as-usual" (BAU) pathology tests. 

"While testing rates have recovered from pandemic lows, the recovery has been slower than expected across the industry," the Celeste team stated.

"In part this has been driven by increased telehealth consultations and in part by staff/patient absenteeism."

It's this second business that the Celeste analysts are hanging their hats on.

"As the endemic phase of COVID-19 annualises, we expect BAU testing to recover to well above pre-COVID levels."

Motley Fool contributor Tony Yoo has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended PWR Holdings. The Motley Fool Australia has positions in and has recommended PWR Holdings. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Cheap Shares

Donor donates blood in medical clinic. Beautiful European woman of 30 years sits in medical chair looking into camera and smiling.
Cheap Shares

2 ASX 200 shares with favourable risk-reward profiles

I think these two blue chips are worth a look right now.

Read more »

A man reacts with surprise when her see a bargain price on his phone.
Cheap Shares

3 cheap ASX 200 shares with big dividends to consider buying right now

These businesses offer impressive levels of passive income.

Read more »

Concept image of a businessman riding a bull on an upwards arrow.
Cheap Shares

3 beaten-down ASX 200 shares to consider buying before the next bull market

These shares could be cheap according to analysts. Here's why now they could be a buy.

Read more »

Some kids fly a kite in strong winds at sunset.
Cheap Shares

Childcare in focus this Federal Election: how much upside does Macquarie expect for G8 Education shares?

Here’s why a broker is bullish about this stock.

Read more »

Couple looking at their phone surprised, symbolising a bargain buy.
Cheap Shares

I think these 2 cheap ASX shares are buys for value investors

I like the price and potential of these businesses.

Read more »

Cheap Shares

3 oversold ASX shares begging to rebound

Analysts think these shares are too cheap to ignore at current levels.

Read more »

A young woman lifts her red glasses with one hand as she takes a closer look at news about interest rates rising and one expert's surprising recommendation as to which ASX shares to buy
Cheap Shares

Down 20% to 40%: These oversold ASX shares could be bargains hiding in plain sight

These shares could be bargain buys according to analysts.

Read more »

a group of people in business attire gather around a computer in an office environment with expressions of concern as they try to nut out the answer to a challenge they are facing.
Cheap Shares

2 ASX 200 stocks this expert thinks are 'extremely compelling'

Here’s why these businesses could be really attractive.

Read more »